Esculetin can also cause the loss of mitochondrial membrane potential in pancreatic cancer cells and increase the cytoplasmic level of cytochrome C, which in turn mediates the activation of caspase-3 and caspase-9, leading to apoptosis. Here, CASP3 is linked to pancreatic neoplasm.